TRU-SENTIMENT · DeltaNeutral
HROW Trading Analysis - 11/16/2026 04:21 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
HROW (Harrow Inc. Common Stock) at $29.12. True Sentiment Bullish, delta 40-60 call 96% / put 4%, call $58,370 vs put $2,140. RSI 54.6.
- Symbol
- HROW
- Price
- $29.12
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- low
- Published
- 2026-11-16 16:21:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)From HROW_options_20261116 data: Sentiment Bullish. Call dollar vol $58,370 (96.5%), Put $2,140 (3.5%). Contracts: 79 call / 6 put. Total analyzed 404, true filter 6 (1.5%).
Call Volume: $58,370 (96.5%) Put Volume: $2,140 (3.5%) Total: $60,510
Pure directional conviction strongly bullish via calls. Divergence: technicals show no clear direction (MACD neg, below SMA50) while options flow bullish – matches spread recommendation "divergence detected".
Key Statistics: HROW
Fundamental Snapshot
Valuation
| P/E (trailing) | 39.60 |
| EPS (trailing 12 mo) | $-0.76 |
| Market cap | $1.09B |
| Shares outstanding | 37.5M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| Beta | 1.71 |
| 52-week low | $25.76 |
| 52-week high | $54.85 |
| Historical volatility | 60.8% |
Ownership & trading
| Institutional ownership | 34.6% |
| Average daily volume | 0.7M sh |
Reported figures; no analyst estimates.
📈 Analysis
News Headlines & Context
The following items are based on general knowledge of HROW (Harrow Health) and are provided as context only, separate from the data-driven analysis below.
- Harrow Health reported Q3 2026 results showing continued revenue growth in its ophthalmic pharmaceutical segment, with management citing expanded commercial footprint.
- Company announced a new FDA-approved compounded medication launch in late October 2026, viewed as a potential catalyst for forward earnings.
- Biotech/specialty pharma sector saw renewed interest in November 2026 after a broader market risk-on move, lifting small-cap names like HROW.
- No confirmed near-term earnings date post November 13, but historical fiscal year-end is December 1, suggesting upcoming financial disclosures.
- Headlines of product expansion align with the sharp November 10 volume spike (1.9M shares) and subsequent options bullishness in the embedded data.
Fundamental Analysis
Based strictly on the provided FUNDAMENTALS data for HROW:
- Trailing P/E is 39.60 with trailing EPS of -0.76 (negative earnings). No forward P/E, PEG, or revenue data supplied.
- Market cap is $1,088,457,000 with 37,533,000 shares outstanding; dividend yield 0.00% (no dividend).
- Beta is 1.71 (high relative volatility vs market); 52-week range $25.76 to $54.85, price well below midpoint.
- Institutional ownership 34.61%; average volume 699,000; historical volatility 60.77% (elevated).
- Key concerns: Negative EPS, no margin/ROE/debt-to-equity/free cash flow data; no analyst target or consensus provided.
- Fundamentals (negative earnings, rich P/E) diverge from options sentiment (bullish) and recent price rebound off 52-week low.
Current Market Position
From embedded data: Daily close on 2026-11-13 was $30.02. Minute bars show 2026-11-13 open $28.37, high $31.10, low $28.31, close $30.02 (volume 628,622). Last minute bar 2026-11-16 15:50 close $29.12 (day high $29.27, low $29.04). Intraday 11-16 shows mild drift lower from $29.27 to $29.12 on thinning volume (<9k/bar). Recent price action: drop to $25.76 (11-06), rebound to $33.68 (11-10), settle ~$28–30.
Technical Analysis
Technical Indicators
Price ($30.02) is above SMA 5 ($29.00) and SMA 20 ($28.48) but below SMA 50 ($30.77) – no golden cross, slight bearish alignment vs 50-day. RSI 54.61 = neutral momentum. MACD -0.54 below signal -0.43, histogram -0.11 (bearish mild). Bollinger: price inside bands, mid $28.48, upper $30.54 (price near upper). 30-day range $25.76–$33.68; price at ~57% of range. ATR $1.94 shows elevated daily swing.
True Sentiment Analysis (Delta 40-60 Options)
From HROW_options_20261116 data: Sentiment Bullish. Call dollar vol $58,370 (96.5%), Put $2,140 (3.5%). Contracts: 79 call / 6 put. Total analyzed 404, true filter 6 (1.5%).
Call Volume: $58,370 (96.5%) Put Volume: $2,140 (3.5%) Total: $60,510
Pure directional conviction strongly bullish via calls. Divergence: technicals show no clear direction (MACD neg, below SMA50) while options flow bullish – matches spread recommendation "divergence detected".
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.